| scholarly article | Q13442814 |
| P50 | author | Claus Claussen | Q16006162 |
| P2093 | author name string | C Pfannenberg | |
| S Miller | |||
| P Aschoff | |||
| S Beckert | |||
| N Schwenzer | |||
| A Koenigsrainer | |||
| B Klumpp | |||
| I Koenigsrainer | |||
| P2860 | cites work | Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial | Q81545779 |
| Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer | Q84529939 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients | Q84605958 | ||
| Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study | Q95383964 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial | Q34928467 | ||
| Future directions in the surgical management of ovarian cancer | Q35203003 | ||
| Experience after 100 patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy | Q35929166 | ||
| Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year | Q36138134 | ||
| Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy | Q36753448 | ||
| Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI. | Q36911315 | ||
| Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival | Q37053323 | ||
| Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy | Q37090867 | ||
| Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis | Q37094755 | ||
| Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients | Q43421690 | ||
| Long-term follow-up in the treatment of peritoneal carcinomatosis | Q44065571 | ||
| Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI. | Q44076876 | ||
| (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy | Q46104163 | ||
| Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis | Q46314349 | ||
| Initial results after implementation of a multimodal treatment for peritoneal malignancies. | Q52895153 | ||
| A critique of surgical cytoreduction in advanced ovarian cancer. | Q52925628 | ||
| Extraovarian primary peritoneal carcinoma: staging with 18F-FDG PET/CT. | Q53239060 | ||
| Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. | Q53599026 | ||
| Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging | Q57944299 | ||
| Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings | Q58484637 | ||
| Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery | Q71796147 | ||
| Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT | Q72176272 | ||
| Evaluation of computed tomography in patients with peritoneal carcinomatosis | Q72873199 | ||
| Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique | Q73327596 | ||
| Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT | Q73551473 | ||
| CT appearance of disseminated peritoneal adenomucinosis | Q74149135 | ||
| Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination--a longitudinal study | Q77400872 | ||
| Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings | Q80738510 | ||
| Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy | Q81484790 | ||
| P433 | issue | 4 | |
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| P304 | page(s) | 540-547 | |
| P577 | publication date | 2013-12-30 | |
| P1433 | published in | Cancer Imaging | Q2577267 |
| P1476 | title | Correlation of preoperative magnetic resonance imaging of peritoneal carcinomatosis and clinical outcome after peritonectomy and HIPEC after 3 years of follow-up: preliminary results | |
| P478 | volume | 13 |
| Q38601896 | Are positron emission tomography-computed tomography (PET-CT) scans useful in preoperative assessment of patients with peritoneal disease before cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)? |
| Q53646381 | Comparison between MRI and CT in prediction of peritoneal carcinomatosis index (PCI) in patients undergoing cytoreductive surgery in relation to the experience of the radiologist. |
| Q38645300 | Diagnostic value of contrast-enhanced CT combined with 18-FDG PET in patients selected for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). |
| Q40350439 | Laparoscopy is Safe and Accurate to Evaluate Peritoneal Surface Metastasis Prior to Cytoreductive Surgery |
| Q58806095 | Outcome and factors associated with aborted cytoreduction for peritoneal carcinomatosis |
| Q49384571 | Prediction of Resectability in Pseudomyxoma Peritonei with a New CT Score |
| Q26768400 | Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy |
Search more.